Literature DB >> 34373270

Adolescent contraception.

Margot A Rosenthal1, Sarah K McQuillan2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34373270      PMCID: PMC8367427          DOI: 10.1503/cmaj.202413

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.

Despite a decreasing incidence of teenage pregnancy in Canada, most pregnancies in adolescents are unplanned

In Canada, 5.3% of live births in 2000, 4% in 2010 and 1.7% in 2019, were to mothers younger than 19 years old.1 More than 80% of adolescent pregnancies, however, are unplanned and many end in termination.2 The Canadian Pediatric Society recommends quick-start methods of contraception and year-long prescriptions to decrease unplanned pregnancies and increase continuation rates.3

Adolescents face multiple barriers when accessing contraception

Many adolescents have concerns with their ability to pay for contraceptives and express difficulty accessing confidential contraceptive care.2 Clinicians should emphasize the benefits of physician–patient confidentiality while explaining the exceptions, including the need to disclose self-harm and activities occurring in a position of vulnerability.

Long-acting reversible contraceptive (LARC) methods are recommended as first-line interventions

In populations in which LARC use is high, adolescent pregnancy rates have declined.3 Levonorgestrel and copper intrauterine devices (IUDs) are effective LARC interventions available in Canada.3 The etonogestrel-releasing implant (Nexplanon) was approved for use in 2020. As it is implanted in the upper arm and does not require a pelvic examination, it may become a popular option among adolescents. After counselling, most adolescents chose a LARC method when it is offered at no cost, with similar uptake of implants and IUDs.4

When prescribing hormonal contraceptives, consider optimization of bone mineral density

Bone mineralization during adolescence represents up to 40% of adult bone mass accrual.5 Prospective studies suggest that oral contraceptives containing ≤ 30 μg of ethinyl estradiol may be insufficient for optimizing bone density. 5 Long-term users of medroxyprogesterone acetate (Depo-Provera) may have decreased bone mineral density; stopping medication can reverse density loss.5 Implants and IUDs do not appear to affect bone accrual.

Encourage concomitant use of barrier contraception to prevent sexually transmitted infections

About 50% of all sexually transmitted infections occur in the 15- to 24-year-old age group, but adolescents using LARCs are 60% less likely to use condoms than those using oral contraceptives.6

CMAJ invites submissions to “Five things to know about …” Submit manuscripts online at http://mc.manuscriptcentral.com/cmaj
  5 in total

Review 1.  Contraceptive care for Canadian youth.

Authors:  Giuseppina Di Meglio; Colleen Crowther; Joanne Simms
Journal:  Paediatr Child Health       Date:  2018-06-12       Impact factor: 2.253

2.  Provision of no-cost, long-acting contraception and teenage pregnancy.

Authors:  Gina M Secura; Tessa Madden; Colleen McNicholas; Jennifer Mullersman; Christina M Buckel; Qiuhong Zhao; Jeffrey F Peipert
Journal:  N Engl J Med       Date:  2014-10-02       Impact factor: 91.245

Review 3.  Bones and Birth Control in Adolescent Girls.

Authors:  Neville H Golden
Journal:  J Pediatr Adolesc Gynecol       Date:  2020-01-20       Impact factor: 1.814

4.  Can youth get the contraception they want? Results of a pilot study in the province of Quebec.

Authors:  Giuseppina Di Meglio; Jessica Yeates; Gillian Seidman
Journal:  Paediatr Child Health       Date:  2019-05-02       Impact factor: 2.253

5.  Long-Acting Reversible Contraception and Condom Use Among Female US High School Students: Implications for Sexually Transmitted Infection Prevention.

Authors:  Riley J Steiner; Nicole Liddon; Andrea L Swartzendruber; Catherine N Rasberry; Jessica M Sales
Journal:  JAMA Pediatr       Date:  2016-05-01       Impact factor: 26.796

  5 in total
  1 in total

1.  "The pill" suppresses adolescent bone growth, no matter the estrogen dose.

Authors:  Tatjana S Brajic; Azita Goshtasebi; Tamara B L Goldberg; Abbey B Berenson; Jerilynn C Prior
Journal:  CMAJ       Date:  2021-12-20       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.